Literature DB >> 25075003

Fusarium peritonitis successfully managed with posaconazole and catheter removal.

Punit J Shah1, Scott Bergman2, Srivalli Vegi3, Vidya Sundareshan3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25075003      PMCID： PMC4114678          DOI： 10.3747/pdi.2013.00142

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  11 in total

1.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

2.  Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.

Authors:  L Joseph Wheat; Patricia Connolly; Melinda Smedema; Michelle Durkin; Edward Brizendine; Paul Mann; Reena Patel; Paul M McNicholas; Mitchell Goldman
Journal:  J Antimicrob Chemother       Date:  2006-04-20       Impact factor: 5.790

Review 3.  Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature.

Authors:  Jorge Garbino; Ilker Uckay; Peter Rohner; Daniel Lew; Christian Van Delden
Journal:  Transpl Int       Date:  2005-05       Impact factor: 3.782

4.  A successfully treated case of peritonitis due to Fusarium dimerum.

Authors:  Soma Gaur; Anupama Rajgopal; Ruth Ashbee
Journal:  J Infect       Date:  2010-03-30       Impact factor: 6.072

5.  Salvage treatment of histoplasmosis with posaconazole.

Authors:  Angela Restrepo; Angela Tobón; Benjamin Clark; Donald R Graham; Gavin Corcoran; Robert W Bradsher; Mitchell Goldman; George Pankey; Thomas Moore; Ricardo Negroni; John R Graybill
Journal:  J Infect       Date:  2006-07-07       Impact factor: 6.072

6.  In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.

Authors:  R K Li; M A Ciblak; N Nordoff; L Pasarell; D W Warnock; M R McGinnis
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 7.  The challenge of managing fusariosis.

Authors:  Maged Muhammed; Jeffrey J Coleman; Herman A Carneiro; Eleftherios Mylonakis
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

8.  Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients.

Authors:  Rhianna Miles; Carmel M Hawley; Stephen P McDonald; Fiona G Brown; Johan B Rosman; Kathryn J Wiggins; Kym M Bannister; David W Johnson
Journal:  Kidney Int       Date:  2009-06-10       Impact factor: 10.612

9.  Voriconazole use for endemic fungal infections.

Authors:  Alison Freifeld; Laurie Proia; David Andes; Larry M Baddour; Janis Blair; Brad Spellberg; Sandra Arnold; Arnold Lentnek; L Joseph Wheat
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

Review 10.  Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature.

Authors:  J T Flynn; D Meislich; B A Kaiser; M S Polinsky; H J Baluarte
Journal:  Perit Dial Int       Date:  1996 Jan-Feb       Impact factor: 1.756
View more
  1 in total

1.  Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.

Authors:  Abdullah M S Al-Hatmi; Anne-Cécile Normand; Stephane Ranque; Renaud Piarroux; G Sybren de Hoog; Joseph Meletiadis; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.